Immatics (IMTX) Times Interest Earned (2019 - 2025)
Immatics (IMTX) reported Times Interest Earned of $161.2 for Q4 2025, up 453.98% on a YoY basis from $29.1 in Q4 2024, and down 8.58% sequentially from $176.34 in Q3 2025.
Immatics (IMTX) Times Interest Earned (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Times Interest Earned data on file, last reported at $161.2 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned rose 453.98% year-over-year to $161.2; the trailing twelve-month figure through Dec 2025 stood at $6.55 (up 1031.57% YoY), and the FY2025 full-year result was $4.96, down 83.02% from the prior year.
- Times Interest Earned declined to $161.2 in Q4 2025, from $176.34 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $176.34 in Q3 2025 to a low of -$75.69 in Q1 2022.
- A 5-year average of $38.57 and a median of $21.08 in 2023 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned sank 485.42% in 2022 and jumped 14756.71% in 2025, its largest moves.
- Tracing IMTX's Times Interest Earned over 5 years: stood at $52.49 in 2021, then slumped by 110.82% to -$5.68 in 2022, then jumped by 276.7% to $10.04 in 2023, then soared by 189.96% to $29.1 in 2024, then jumped by 453.98% to $161.2 in 2025.
- Business Quant data shows IMTX's Times Interest Earned at $161.2 in Q4 2025, $176.34 in Q3 2025, and $4.13 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | 161.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 161.20 |
| Sep 30, 2025 | 176.34 |
| Jun 30, 2025 | 4.13 |
| Mar 31, 2025 | 4.06 |
| Dec 31, 2024 | 29.10 |
| Sep 30, 2024 | 1.19 |
| Jun 30, 2024 | 59.53 |
| Mar 31, 2024 | 3.54 |
| Dec 31, 2023 | 10.04 |
| Sep 30, 2023 | 17.82 |
| Jun 30, 2023 | 22.51 |
| Mar 31, 2023 | 6.63 |
| Dec 31, 2022 | -5.68 |
| Sep 30, 2022 | 48.83 |
| Jun 30, 2022 | 32.54 |
| Mar 31, 2022 | -75.69 |
| Dec 31, 2021 | 52.49 |
| Sep 30, 2021 | 160.08 |
| Jun 30, 2021 | 43.18 |
| Mar 31, 2021 | 19.64 |